• At Pharmaceutical Specialties, Inc. patient care comes first.
products. Trio
  The Trio® Electronic Nebulizer is a highly efficient nebulizer that boosts the effectiveness of medication delivery while significantly decreasing standard treatment times. This new technology utilizes a vibrating membrane for liquid aerosol generation.

Its high flow rate and a high percentage of the delivered dose within the respirable range significantly reduces nebulization times, thereby
 
 
allowing for better control of symptoms and an improved quality of life for patients. Plus, the eFlow ® is silent, small, and lightweight, and can be customized based on each medication’s formulation.
  

  As a member of the Respiratory Disease Network, Pharmaceutical Specialties is the sole provider of eFlow ® and accompanying medicines for patients in Alabama, Georgia, North Carolina, South Carolina, Virginia, Washington DC, and now for those with traditional Florida Medicaid.

For more information on the eFlow, or to see if it’s the right choice for you, contact us today. 

Click here for the Trio ® Prescription Form (PDF)
    
 
*Disclaimer: The eFlow ® nebulizer has not undergone human clinical studies to determine its safety or efficacy and has not been approved by the FDA for use with tobramycin in the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis. Compounded prescriptions are not evaluated by the FDA for safety or efficacy.
 
       

the latest. news


Bringing the pieces together......



Pharmaceutical Specialties, Inc. approved by Wellcare of Georgia to provide Cayston to Wellcare Medicaid of GA recipients.
       
        http://georgia.wellcare.com/
        Georgia Wellcare, January 15, 2011

Pharmaceutical Specialties, Inc. is supporting the Pediatric Nurses Society and attending the National Meeting in Orlando in April.

Pharmaceutical Specialties, Inc. recently attended the Annual Liver Symposia at Duke Medical Center.